Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9167 |
High Similarity |
NPD6651 |
Approved |
0.916 |
High Similarity |
NPD1240 |
Approved |
0.9023 |
High Similarity |
NPD1607 |
Approved |
0.8993 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD1510 |
Phase 2 |
0.8759 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8759 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD1549 |
Phase 2 |
0.8681 |
High Similarity |
NPD4380 |
Phase 2 |
0.8633 |
High Similarity |
NPD2800 |
Approved |
0.8621 |
High Similarity |
NPD7411 |
Suspended |
0.8571 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8456 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8417 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8378 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8311 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8298 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8264 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8255 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1934 |
Approved |
0.817 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8133 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8129 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8043 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8026 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8026 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7986 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7902 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7843 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD943 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5711 |
Approved |
0.775 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7733 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7733 |
Intermediate Similarity |
NPD920 |
Approved |
0.7724 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7703 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7681 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7677 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD5494 |
Approved |
0.764 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7626 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD5401 |
Approved |
0.76 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7591 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7546 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7534 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7517 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7463 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD919 |
Approved |
0.7353 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7353 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7349 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7305 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5405 |
Approved |
0.729 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD1201 |
Approved |
0.726 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7241 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7114 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7113 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3225 |
Approved |
0.711 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD3764 |
Approved |
0.705 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7044 |
Intermediate Similarity |
NPD37 |
Approved |
0.7032 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7022 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1283 |
Approved |
0.6987 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6985 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6982 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6981 |
Remote Similarity |
NPD5890 |
Approved |
0.6981 |
Remote Similarity |
NPD5889 |
Approved |
0.6966 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4288 |
Approved |
0.6957 |
Remote Similarity |
NPD2296 |
Approved |
0.695 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6939 |
Remote Similarity |
NPD411 |
Approved |
0.6939 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6928 |
Remote Similarity |
NPD2403 |
Approved |
0.6923 |
Remote Similarity |
NPD4749 |
Approved |
0.6923 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD940 |
Approved |
0.6923 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD846 |
Approved |
0.6918 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6914 |
Remote Similarity |
NPD4965 |
Approved |
0.6914 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD4966 |
Approved |
0.6913 |
Remote Similarity |
NPD447 |
Suspended |
0.6909 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6908 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6897 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6897 |
Remote Similarity |
NPD4287 |
Approved |
0.6885 |
Remote Similarity |
NPD7584 |
Approved |
0.6879 |
Remote Similarity |
NPD4626 |
Approved |
0.6879 |
Remote Similarity |
NPD17 |
Approved |
0.6866 |
Remote Similarity |
NPD9266 |
Approved |
0.6866 |
Remote Similarity |
NPD74 |
Approved |
0.6857 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6855 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD9494 |
Approved |
0.6849 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD1613 |
Approved |
0.6846 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD4477 |
Approved |
0.6842 |
Remote Similarity |
NPD4476 |
Approved |
0.6839 |
Remote Similarity |
NPD2354 |
Approved |
0.6839
|
Remote Similarity |
NPD3295 |
Clinical (unspecified phase) |